Showing 14,761 - 14,780 results of 46,952 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( 5 ((wt decrease) OR (mean decrease)) ))', query time: 1.13s Refine Results
  1. 14761

    Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma by Bo Li (112195)

    Published 2020
    “…Herein, we report the structure-guided development of a series of covalent inhibitors of FAK. These new compounds displayed highly potent inhibitory potency against FAK enzymatic activity with IC<sub>50</sub> values in the nanomolar range. …”
  2. 14762
  3. 14763

    Presentation1_The impact of Climate Change on extreme winds over northern Europe according to CMIP6.pdf by Xiaoli Guo Larsén (12502987)

    Published 2024
    “…We obtain the possible effect of climate change through the comparison of the extreme wind parameters, including the 50-year wind and the 95%-percentile of the wind speed, and the change in turbine class at 50 m, 100 m and 200 m, between a near future period (2020–2049) and the historic period (1980–2009). …”
  4. 14764

    Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (<i>S</i>, <i>Se</i>) and Their Azole Derivatives against Chagas Disease by Mercedes Rubio-Hernández (20036142)

    Published 2024
    “…Seleno-compounds demonstrated enhanced activity and selenazoles showed a decrease in selenium-associated toxicity. Compound 4-methyl-2-(2-(1-(3-nitrophenyl)­ethylidene)­hydrazineyl)-1,3-selenazole (<i><b>Se</b></i><b>2h</b>) emerged as a promising candidate, and its binding to cruzain was investigated. …”
  5. 14765

    Synthesis and Biological Evaluation of New Chalcogen Semicarbazone (<i>S</i>, <i>Se</i>) and Their Azole Derivatives against Chagas Disease by Mercedes Rubio-Hernández (20036142)

    Published 2024
    “…Seleno-compounds demonstrated enhanced activity and selenazoles showed a decrease in selenium-associated toxicity. Compound 4-methyl-2-(2-(1-(3-nitrophenyl)­ethylidene)­hydrazineyl)-1,3-selenazole (<i><b>Se</b></i><b>2h</b>) emerged as a promising candidate, and its binding to cruzain was investigated. …”
  6. 14766
  7. 14767
  8. 14768

    S1 Dataset - by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  9. 14769

    EBBS frequencies, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  10. 14770

    EBBS summative indices, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  11. 14771

    Exercise Habits, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  12. 14772

    Adjusted odds ratios. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  13. 14773

    Obstetric and health characteristics, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  14. 14774

    Physical activity summative indices, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  15. 14775

    Sociodemographic characteristics, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…The mean age of the study participants was 26.1 (±5.9) years. 89% of the pregnant women did not meet the WHO recommendations of 150 minutes of moderate-intensity PA. …”
  16. 14776

    Potent 5‑Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1–UBE2M Interaction by Wenjuan Zhou (115285)

    Published 2019
    “…After finding a novel inhibitor <b>DC-1</b> with IC<sub>50</sub> = 1.2 μM, we performed a series of chemical optimizations, which finally led to the discovery of a potent thiazole containing 5-cyano-6-phenylpyrimidin-based inhibitor <b>DC-2</b> (IC<sub>50</sub> = 15 nM). …”
  17. 14777

    Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis by Guoli Yan (4591687)

    Published 2019
    “…Fixed-effects and random-effects meta-analyses were performed to pool the relative risks (RRs), hazard ratios (HRs) and weighted mean difference (WMD). Publication bias and heterogeneity were examined. …”
  18. 14778
  19. 14779

    GSH evokes increase in the extracellular GABA levels in chick retinal tissue and in mixed neuronal-glial cells in culture. by Hercules R. Freitas (3174633)

    Published 2016
    “…<p>GSH treatment evokes GABA release in chick retinal tissue or in cells in culture (A) Extracellular GABA levels were measured in E11 avian retina upon incubation with 1–5mM GSH for 10 min. Values are means ± SD from two independent experiments (ANOVA-Tukey *<i>p</i> < 0.01 vs. control, n ≥ 4). …”
  20. 14780

    List of antibodies used in this study. by Riya Ghosh (17116962)

    Published 2025
    “…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”